Privacy Policy

As a SUD treatment provider, we are subject to enhanced privacy protections under 42 CFR Part 2, which provides stricter confidentiality requirements than HIPAA for substance use disorder patient records. Under these regulations:

• Your SUD treatment records are protected with the highest level of federal confidentiality.
• We cannot disclose that you are or were a patient, or any information identifying you as having a substance use disorder, without your specific written consent, except in limited circumstances permitted by law.
• Your records may not be used to investigate or prosecute you for any criminal activity.
• Any disclosure made with your consent must be accompanied by a written statement prohibiting re-disclosure.
• We maintain a Notice of Privacy Practices detailing your rights under HIPAA, which is provided upon intake.

Federal Re-Disclosure Prohibition Notice (42 CFR Part 2)

This information has been disclosed to you from records protected by Federal confidentiality rules (42 CFR Part 2). The Federal rules prohibit you from making any further disclosure of information in this record that identifies a patient as having or having had a substance use disorder either directly, by reference to publicly available information, or through verification of such identification by another person unless further disclosure is expressly permitted by the written consent of the individual whose information is being disclosed or as otherwise permitted by 42 CFR Part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose (see § 2.31). The Federal rules restrict any use of the information to investigate or prosecute with regard to a crime any patient with a substance use disorder, except as provided at §§ 2.12(c)(5) and 2.65.